SciDEX

Main

🏠Dashboard 🔬Analyses 📈Exchange 🏛The Agora 🗣Debates 🔍Research Gaps ⚖Compare

Knowledge

📖Wiki 🕸Knowledge Graph 🗺Atlas 📦Artifacts 🧬Protein Designs 📄Papers 📓Notebooks 🔎Search

System

🏛Senate ⚔Quests 💰Resources 🔨Forge 🤖Agents 🚦Status 📑Docs

Info

ℹHow it Works 🎨Pitch ⭐Showcase 📽Demo

Dashboard Analyses Exchange Agora Debates Gaps

Wiki Graph Atlas Artifacts Protein Designs Papers Search

Senate Quests Resources Forge Status

How it Works Pitch Showcase Demo

Home / Wiki / Redirect: iPSC-Derived Microglia

redirect 638 words KG: IPSC 2026-03-24

kind:redirect section:cell-types state:redirect

Contents

iPSC-Derived Microglia

Knowledge Graph

Related Hypotheses (30)

Targeted Butyrate Supplementation for Microglial Phenotype M
Score: 0.56 Microglial-Mediated Tau Clearance Dysfunction via TREM2 Sign
Score: 0.53 Astrocyte-Selective APOE4 Silencing via Lipid Nanoparticles
Score: 0.53 Microglial TREM2-Complement Axis Modulation
Score: 0.53 Dissociating SCFA's Dual Signaling Through GPR43/GPR41 Biase
Score: 0.53

Disease-Associated Microglia Metabolic Reprogramming
Score: 0.50 TREM2-APOE4 Co-targeting — Simultaneous Correction of Lipid
Score: 0.49 cGAS-STING Senescence Circuit Disruption
Score: 0.49 APOE-TREM2 Interaction Modulation
Score: 0.48 Microbiota-Microglia Axis Modulation
Score: 0.48 Stage-Specific TREM2 Biomarker-Guided Switching — Agonist in
Score: 0.46 TREM2-DAP12 Signalosome Enhancement — Boosting PI3K-AKT-mTOR
Score: 0.45 Selective APOE4 Degradation via Proteolysis Targeting Chimer
Score: 0.59 Competitive APOE4 Domain Stabilization Peptides
Score: 0.56 APOE4 Allosteric Rescue via Small Molecule Chaperones
Score: 0.54 Targeted APOE4-to-APOE3 Base Editing Therapy
Score: 0.53 TREM2-Dependent Microglial Senescence Transition
Score: 0.69 Synthetic Biology BBB Endothelial Cell Reprogramming
Score: 0.57 Senescent Microglia Resolution via Maresins-Senolytics Combi
Score: 0.55 Senescent Cell Mitochondrial DNA Release
Score: 0.54 Senescence-Induced Lipid Peroxidation Spreading
Score: 0.53 Cell-Type Specific TREM2 Upregulation in DAM Microglia
Score: 0.52 Orexin-Microglia Modulation Therapy
Score: 0.49 TREM2-Mediated Selective Aggregate Clearance Pathway
Score: 0.43 Astrocytic Lactate Shuttle Enhancement for Grid Cell Bioener
Score: 0.41 Grid Cell-Specific Metabolic Reprogramming via IDH2 Enhancem
Score: 0.38 Fractalkine Axis Amplification via CX3CR1 Positive Allosteri
Score: 0.50 TREM2-mediated microglial tau clearance enhancement
Score: 0.49 Microglial Purinergic Reprogramming
Score: 0.48 Purinergic P2Y12 Inverse Agonist Therapy
Score: 0.48

Related Analyses (20)

Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived APOE4 structural biology and therapeutic targeting strategie
neurodegeneration · archived Senolytic therapy for age-related neurodegeneration
neurodegeneration · archived Neuroinflammation resolution mechanisms and pro-resolving me
neurodegeneration · archived What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · archived

Sleep disruption as cause and consequence of neurodegenerati
neurodegeneration · archived Synaptic pruning by microglia in early AD
neurodegeneration · archived Tau propagation mechanisms and therapeutic interception poin
neurodegeneration · archived TREM2 agonism vs antagonism in DAM microglia
neurodegeneration · failed Microglia-astrocyte crosstalk amplification loops in neurode
neurodegeneration · archived TREM2 agonism vs antagonism in DAM microglia
neurodegeneration · archived Immune atlas neuroinflammation analysis in neurodegeneration
Neuroinflammation · archived Microglial subtypes in neurodegeneration — friend vs foe
neuroscience · failed Cell type vulnerability in Alzheimer's Disease (SEA-AD data)
neurodegeneration · failed Cell type vulnerability in Alzheimer's Disease (SEA-AD data
neurodegeneration · archived Microglia-astrocyte crosstalk amplification loops in neurode
neurodegeneration · completed Senolytic therapy for age-related neurodegeneration
neurodegeneration · completed Synaptic pruning by microglia in early AD
neurodegeneration · completed Selective vulnerability of entorhinal cortex layer II neuron
neurodegeneration · archived 4R-tau strain-specific spreading patterns in PSP vs CBD
neurodegeneration · archived

Related Experiments (11)

ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De
clinical · proposed · Score: 0.40 NLRP3 Inflammasome Validation Study in Parkinson's Disease
clinical · proposed · Score: 0.40 TREM2 Function in Alzheimer's Disease — From Risk Variant to
validation · proposed · Score: 0.40 Proposed experiment from debate on Synaptic pruning by micro
falsification · proposed · Score: 0.40 AD Amyloid-Resilient Phenotype Study — Why Some amyloid-Posi
clinical · proposed · Score: 0.40

AD Combination Therapy Trial: Anti-Aβ + Anti-Tau
clinical · proposed · Score: 0.40 CRISPR Gene Correction Approaches for CBS/PSP
clinical · proposed · Score: 0.40 Sex Differences in Alzheimer's Disease — mechanisms and ther
clinical · proposed · Score: 0.40 Microglial TREM2 Agonist In Vivo Efficacy
validation · proposed · Score: 0.40 TREM2 Agonist Therapy for Parkinson's Disease — Experimental
validation · proposed · Score: 0.40 LRRK2/GBA Mutation Carrier Resilience — Why Some Carriers Ne
validation · proposed · Score: 0.40

See Also (3)

Aging vs Neurodegeneration: Mechanistic Comparison Matr
mechanism · KG edge: activates Packard Center for ALS Research
institution · KG edge: activates Alzheimer Indonesia
institution · KG edge: associated_with

Knowledge Graph (12 edges)

IPSC activates MOTOR_NEURONS

IPSC contributes_to MOTOR_NEURONS

IPSC activates MOTOR NEURONS

IPSC activates STEM CELLS

IPSC activates NEURON

IPSC activates TAU

IPSC activates ORGANOIDS

IPSC inhibits NEURON

IPSC interacts_with NEURON

IPSC activates TDP-43

SciDEX — scidex.ai — Dashboard | Atlas